Tender

Human Normal Intravenous Immunoglobulin Evidence Reviews

NHS COMMISSIONING BOARD

This public procurement record has 1 release in its history.

Tender

22 Dec 2017 at 16:01

Tender Notice
Summary of the contracting process

The NHS Commissioning Board is currently in the tender stage of the procurement process for the project titled "Human Normal Intravenous Immunoglobulin Evidence Reviews," with an estimated value of £130,000. This initiative falls under the industry category of general management consultancy services, specifically aimed at supporting the Blood and Infection Programme of Care. The tender period is set to conclude on 12th January 2018, and the contract is expected to commence on 2nd March 2018, lasting until 31st March 2018. Interested parties must express their interest via email by the specified deadline and ensure registration on Bravo Solutions to access the tender documents.

This tender presents a significant opportunity for businesses specialising in clinical evidence reviews, particularly those experienced in conducting systematic reviews related to immunoglobulin and other healthcare consultancy services. It is tailored for small and medium-sized enterprises (SMEs) that possess the capability to deliver evidence-based assessments and have strong analytical skills. Companies engaged in evaluation consultancy services or those with expertise in health-related research will likely find this tender particularly suited to their offerings, encouraging them to participate in a competitive process that could enhance their visibility and contract portfolio within the healthcare sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Human Normal Intravenous Immunoglobulin Evidence Reviews

Notice Description

The Blood and Infection Programme of Care is seeking support for it Immunoglobulin Improving Value Project. Immunoglobulin is commissioned by NHS England in line with Department of Health Clinical guidelines for immunoglobulin use. https://www.gov.uk/government/publications/clinical-guidelines-for-immunoglobulin-use-second-edition-update The guidelines state which conditions immunoglobulin is recommended for and these are colour coded according to priority. A red classification indicates the highest priority as there could be a risk to life without treatment. A blue classification is for those indications where there is some evidence of benefit but for which there may be alternative treatments and for which treatment may be modified in times of supply shortages of immunoglobulin. Grey indications are those for which the evidence is weak, including rare disorders. It is envisaged that the successful organisation will be able to provide the required clinical evidence reviews to meet our objectives of providing safe, effective, evidence based care and will have the relevant experience, knowledge and capability to carry out detailed clinical evidence reviews for the grey indications from the Clinical Guidelines for Immunoglobulin Use 2nd edition. It is expected the chosen provider will be able to carry out the following: Scoping reviews to identify literature reporting on the use of immunoglobulin, in people with a grey indication. It would include a scoping of the literature to: 1. Identifying the research question (PICO) 2. Identifying relevant studies (search) 3. Study selection 4. Charting data 5. Collating, summarising and reporting results, interpretation and conclusions Then provide rapid reviews for those indications where there are experimental controlled trials or observational studies with a control group including: 1. Assessing quality of included literature 2. Measures of treatment effect 3. Summarising and interpreting results Please note that that this contract may be extended for an additional 3 months. Interested parties must be registered on Bravo Solutions in order to access the ITT documents. Please use the following address if you are not already registered: https://nhsengland.bravosolution.co.uk/web/login.html. IN ADDITION, PLEASE ENSURE YOU EMAIL VANESSA.AMISSAH@NHS.NET TO EXPRESS AN INTEREST BY FRIDAY 12TH JANUARY 2018, 12 NOON, AT THE LATEST. IT IS ENVISAGED THAT THE INVITATION TO TENDER DOCUMENTS WILL BE MADE AVAILABLE BY MID-LATE JANUARY 2018.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/f1a2a6b4-2233-43c8-bb15-b2667cbadc09
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Limited
Procurement Method Details
Competitive quotation (below threshold)
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

79 - Business services: law, marketing, consulting, recruitment, printing and security

CPV Codes

79411000 - General management consultancy services

79419000 - Evaluation consultancy services

Notice Value(s)

Tender Value
£130,000 £100K-£500K
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
22 Dec 20178 years ago
Submission Deadline
12 Jan 2018Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
2 Mar 2018 - 31 Mar 2018 30 days
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS COMMISSIONING BOARD
Contact Name
Vanessa Amissah
Contact Email
vanessa.amissah@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LONDON
Postcode
NW1 2PL
Post Town
North West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI36 Camden
Delivery Location
TLI London
Local Authority
Camden
Electoral Ward
Regent's Park
Westminster Constituency
Holborn and St Pancras

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd-2017-12-22T16:01:43Z",
    "date": "2017-12-22T16:01:43Z",
    "ocid": "ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "17_10_03",
        "title": "Human Normal Intravenous Immunoglobulin Evidence Reviews",
        "description": "The Blood and Infection Programme of Care is seeking support for it Immunoglobulin Improving Value Project. Immunoglobulin is commissioned by NHS England in line with Department of Health Clinical guidelines for immunoglobulin use. https://www.gov.uk/government/publications/clinical-guidelines-for-immunoglobulin-use-second-edition-update The guidelines state which conditions immunoglobulin is recommended for and these are colour coded according to priority. A red classification indicates the highest priority as there could be a risk to life without treatment. A blue classification is for those indications where there is some evidence of benefit but for which there may be alternative treatments and for which treatment may be modified in times of supply shortages of immunoglobulin. Grey indications are those for which the evidence is weak, including rare disorders. It is envisaged that the successful organisation will be able to provide the required clinical evidence reviews to meet our objectives of providing safe, effective, evidence based care and will have the relevant experience, knowledge and capability to carry out detailed clinical evidence reviews for the grey indications from the Clinical Guidelines for Immunoglobulin Use 2nd edition. It is expected the chosen provider will be able to carry out the following: Scoping reviews to identify literature reporting on the use of immunoglobulin, in people with a grey indication. It would include a scoping of the literature to: 1. Identifying the research question (PICO) 2. Identifying relevant studies (search) 3. Study selection 4. Charting data 5. Collating, summarising and reporting results, interpretation and conclusions Then provide rapid reviews for those indications where there are experimental controlled trials or observational studies with a control group including: 1. Assessing quality of included literature 2. Measures of treatment effect 3. Summarising and interpreting results Please note that that this contract may be extended for an additional 3 months. Interested parties must be registered on Bravo Solutions in order to access the ITT documents. Please use the following address if you are not already registered: https://nhsengland.bravosolution.co.uk/web/login.html. IN ADDITION, PLEASE ENSURE YOU EMAIL VANESSA.AMISSAH@NHS.NET TO EXPRESS AN INTEREST BY FRIDAY 12TH JANUARY 2018, 12 NOON, AT THE LATEST. IT IS ENVISAGED THAT THE INVITATION TO TENDER DOCUMENTS WILL BE MADE AVAILABLE BY MID-LATE JANUARY 2018.",
        "datePublished": "2017-12-22T16:01:43Z",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "79411000",
            "description": "General management consultancy services"
        },
        "additionalClassifications": [
            {
                "scheme": "CPV",
                "id": "79419000",
                "description": "Evaluation consultancy services"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 130000,
            "currency": "GBP"
        },
        "procurementMethod": "limited",
        "procurementMethodDetails": "Competitive quotation (below threshold)",
        "tenderPeriod": {
            "endDate": "2018-01-12T23:59:59Z"
        },
        "contractPeriod": {
            "startDate": "2018-03-02T00:00:00Z",
            "endDate": "2018-03-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/f1a2a6b4-2233-43c8-bb15-b2667cbadc09",
                "datePublished": "2017-12-22T16:01:43Z",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-74704",
            "name": "NHS COMMISSIONING BOARD",
            "identifier": {
                "legalName": "NHS COMMISSIONING BOARD"
            },
            "address": {
                "streetAddress": "5th Floor Stephenson House",
                "locality": "London",
                "postalCode": "NW1 2PL",
                "countryName": "England"
            },
            "contactPoint": {
                "name": "Vanessa Amissah",
                "email": "vanessa.amissah@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-74704",
        "name": "NHS COMMISSIONING BOARD"
    }
}